Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 814.99M | 793.17M | 780.98M | 840.20M | 601.20M |
| Total Depreciation and Amortization | 383.88M | 383.88M | 334.42M | 352.21M | 334.39M |
| Total Amortization of Deferred Charges | 45.97M | 45.97M | 26.49M | 38.90M | 26.60M |
| Total Other Non-Cash Items | 229.90M | 94.74M | 208.82M | 71.41M | 897.91M |
| Change in Net Operating Assets | -452.40M | -452.40M | -598.82M | -424.16M | -596.17M |
| Cash from Operations | 1.02B | 865.35M | 751.89M | 878.57M | 1.26B |
| Capital Expenditure | -322.77M | -323.73M | -301.68M | -295.31M | -312.76M |
| Sale of Property, Plant, and Equipment | 28.25M | 14.62M | 22.96M | 24.04M | 35.53M |
| Cash Acquisitions | -35.19M | -37.75M | -89.62M | -86.91M | -13.79M |
| Divestitures | 3.80M | 5.60M | 1.61M | 2.33M | 603.20K |
| Other Investing Activities | -139.95M | -216.87M | 266.93M | -40.82M | -42.84M |
| Cash from Investing | -465.86M | -558.13M | -99.80M | -396.67M | -333.27M |
| Total Debt Issued | 69.53B | 69.39B | 75.64B | 74.13B | 75.70B |
| Total Debt Repaid | -74.73B | -71.23B | -73.97B | -71.53B | -72.79B |
| Issuance of Common Stock | 0.00 | 7.38M | 75.26M | 89.83M | 93.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -428.97M | -390.07M | -397.03M | -488.54M | -492.02M |
| Other Financing Activities | -1.12B | -1.02B | -1.44B | -1.05B | -717.85M |
| Cash from Financing | -1.31B | -804.98M | -363.95M | -268.75M | -182.60M |
| Foreign Exchange rate Adjustments | -2.23M | -407.70K | 1.90M | -479.80K | -215.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -759.95M | -498.17M | 290.04M | 212.67M | 747.85M |